439 related articles for article (PubMed ID: 20674878)
1. Yellow fever vaccination coverage among children in Brazilian capitals.
Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
[TBL] [Abstract][Full Text] [Related]
2. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004.
Huhn GD; Brown J; Perea W; Berthe A; Otero H; LiBeau G; Maksha N; Sankoh M; Montgomery S; Marfin A; Admassu M
Vaccine; 2006 Feb; 24(6):730-7. PubMed ID: 16182416
[TBL] [Abstract][Full Text] [Related]
3. Yellow fever vaccination: how much is enough?
Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
Collaborative Group for Studies with Yellow Fever Vaccine
Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
[TBL] [Abstract][Full Text] [Related]
5. Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007.
Pezzoli L; Pineda S; Halkyer P; Crespo G; Andrews N; Ronveaux O
Trop Med Int Health; 2009 Mar; 14(3):355-61. PubMed ID: 19187516
[TBL] [Abstract][Full Text] [Related]
6. Review of the risks and benefits of yellow fever vaccination including some new analyses.
Monath TP
Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
[TBL] [Abstract][Full Text] [Related]
7. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Staples JE; Gershman M; Fischer M;
MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
[TBL] [Abstract][Full Text] [Related]
8. Late vaccination against yellow fever of travelers visiting endemic countries.
Krief I; Goldblatt JG; Paz A; Potasman I
Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
[TBL] [Abstract][Full Text] [Related]
9. [Yellow fever vaccination: update on rare and severe adverse effects].
Receveur MC; Bruyand M; Pistone T; Malvy D
Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
[TBL] [Abstract][Full Text] [Related]
10. Adverse event reports following yellow fever vaccination.
Lindsey NP; Schroeder BA; Miller ER; Braun MM; Hinckley AF; Marano N; Slade BA; Barnett ED; Brunette GW; Horan K; Staples JE; Kozarsky PE; Hayes EB
Vaccine; 2008 Nov; 26(48):6077-82. PubMed ID: 18809449
[TBL] [Abstract][Full Text] [Related]
11. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
[TBL] [Abstract][Full Text] [Related]
12. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009.
Pezzoli L; Tchio R; Dzossa AD; Ndjomo S; Takeu A; Anya B; Ticha J; Ronveaux O; Lewis RF
Epidemiol Infect; 2012 Jan; 140(1):14-26. PubMed ID: 21418714
[TBL] [Abstract][Full Text] [Related]
13. Prevention of yellow fever in persons traveling to the tropics.
Monath TP; Cetron MS
Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
[TBL] [Abstract][Full Text] [Related]
14. Vaccination coverage in the context of the emerging Yellow Fever threat in French Guiana.
Flamand C; Bailly S; Fritzell C; Fernandes Pellerin S; Toure A; Chateau N; Saout M; Linares S; Dubois F; Filleul L; Kazanji M
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007661. PubMed ID: 31425507
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
Belmusto-Worn VE; Sanchez JL; McCarthy K; Nichols R; Bautista CT; Magill AJ; Pastor-Cauna G; Echevarria C; Laguna-Torres VA; Samame BK; Baldeon ME; Burans JP; Olson JG; Bedford P; Kitchener S; Monath TP
Am J Trop Med Hyg; 2005 Feb; 72(2):189-97. PubMed ID: 15741556
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-related transmission of yellow fever vaccine virus--California, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):34-7. PubMed ID: 20094025
[TBL] [Abstract][Full Text] [Related]
17. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
Suzano CE; Amaral E; Sato HK; Papaiordanou PM;
Vaccine; 2006 Feb; 24(9):1421-6. PubMed ID: 16236402
[TBL] [Abstract][Full Text] [Related]
18. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.
Farez MF; Correale J
Arch Neurol; 2011 Oct; 68(10):1267-71. PubMed ID: 21670384
[TBL] [Abstract][Full Text] [Related]
19. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
O'Brien B; Leggat PA
Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.
Boddington NL; Simons H; Launders N; Gawthrop M; Stillwell A; Wong C; Mathewson J; Hill DR
J Travel Med; 2012; 19(2):84-91. PubMed ID: 22414032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
